» Articles » PMID: 24434111

Sex Differences in Cognitive Impairment and Alzheimer's Disease

Overview
Specialty Endocrinology
Date 2014 Jan 18
PMID 24434111
Citations 224
Authors
Affiliations
Soon will be listed here.
Abstract

Studies have shown differences in specific cognitive ability domains and risk of Alzheimer's disease between the men and women at later age. However it is important to know that sex differences in cognitive function during adulthood may have their basis in both organizational effects, i.e., occurring as early as during the neuronal development period, as well as in activational effects, where the influence of the sex steroids influence brain function in adulthood. Further, the rate of cognitive decline with aging is also different between the sexes. Understanding the biology of sex differences in cognitive function will not only provide insight into Alzheimer's disease prevention, but also is integral to the development of personalized, gender-specific medicine. This review draws on epidemiological, translational, clinical, and basic science studies to assess the impact of sex differences in cognitive function from young to old, and examines the effects of sex hormone treatments on Alzheimer's disease in men and women.

Citing Articles

Protective and risk factors in daily life associated with cognitive decline of older adults.

Tong F, Yang H, Yu H, Sui L, Yao J, Shi C Front Aging Neurosci. 2025; 17:1496677.

PMID: 40078638 PMC: 11897038. DOI: 10.3389/fnagi.2025.1496677.


Age and cognitive skills: Use it or lose it.

Hanushek E, Kinne L, Witthoft F, Woessmann L Sci Adv. 2025; 11(10):eads1560.

PMID: 40043134 PMC: 11881919. DOI: 10.1126/sciadv.ads1560.


Systematic identification and quantification of factors and their interactions with age, sex, and panel wave influencing cognitive function in Korean older adults.

Kim E, Oh J, Gim J, Huh I Front Public Health. 2025; 13:1547575.

PMID: 39963478 PMC: 11831817. DOI: 10.3389/fpubh.2025.1547575.


The influencing factors of cognitive impairment in elderly individuals in Chengdu city: a cross-sectional study based on AD8.

Ruan X, Li H, Wang Z, Wang Y, Nie Y, Li Y BMC Geriatr. 2025; 25(1):19.

PMID: 39789427 PMC: 11715083. DOI: 10.1186/s12877-024-05661-3.


Prevalence of cognitive impairment and its related factors among Chinese older adults: an analysis based on the 2018 CHARLS data.

Wu X, Tang Y, He Y, Wang Q, Wang Y, Qin X Front Public Health. 2025; 12:1500172.

PMID: 39776486 PMC: 11703964. DOI: 10.3389/fpubh.2024.1500172.


References
1.
Kaur P, Jodhka P, Underwood W, Bowles C, de Fiebre N, de Fiebre C . Progesterone increases brain-derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants. J Neurosci Res. 2007; 85(11):2441-9. PMC: 2693123. DOI: 10.1002/jnr.21370. View

2.
Jayaraman A, Carroll J, Morgan T, Lin S, Zhao L, Arimoto J . 17β-estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology. 2012; 153(11):5467-79. PMC: 3473201. DOI: 10.1210/en.2012-1464. View

3.
Anastasio T . Exploring the contribution of estrogen to amyloid-Beta regulation: a novel multifactorial computational modeling approach. Front Pharmacol. 2013; 4:16. PMC: 3585711. DOI: 10.3389/fphar.2013.00016. View

4.
Sohrabji F, Selvamani A, Balden R . Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke. Horm Behav. 2012; 63(2):222-30. PMC: 3483414. DOI: 10.1016/j.yhbeh.2012.06.002. View

5.
Toung T, Traystman R, Hurn P . Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke. 1998; 29(8):1666-70. DOI: 10.1161/01.str.29.8.1666. View